CERo Therapeutics Holdings, Inc. (OTCPK: CERO)
Health Care · Biotechnology · US
$0.01
-4.55% today · -99.8% 1Y
CERo Therapeutics Holdings, Inc. (OTCPK: CERO) operates in the Biotechnology industry within the Health Care sector. The company is valued at $797.17K and employs 8 people.
Over the last twelve months the share price has lost 99.8%, trading between 0.01 and 5.66.
Tweenvest scores CERo Therapeutics Holdings, Inc. across four factors: quality 12/100, value 41/100. Its strongest factor is value.
CERO price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $797.17K
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -4.08
- Dividend yield
- —
- Beta (5Y)
- 0.22
- 52-week high
- $5.66
- 52-week low
- $0.01
- Avg volume (3M)
- —
- Shares outstanding
- 75.92M
- Employees
- 8
- Next earnings
- —
About CERo Therapeutics Holdings, Inc.
CERo Therapeutics Holdings, Inc. is a biotech firm dedicated to pioneering advanced engineered T-cell immunotherapies for the treatment of various cancers. Their leading therapeutic candidate, CER-1236, is an autologous T-cell therapy currently in development, aimed at addressing both blood cancers (hematologic malignancies) and solid tumors. This company was founded in 2021 and is headquartered in South San Francisco, California.
- ISIN
- US71902K4022
- Founded
- 2021
- Listed since
- Nov 30, 2021
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Epigenomics AGDB: ECX | $898.20K | €0.91 | -4.21% |
| Exousia Bio, Inc.OTCPK: LMMY | $887.25K | $0.02 | +5.62% |
| Yubo International Biotech LimitedOTCPK: YBGJ | $886.19K | $0.01 | -51.85% |
| Agentix Corp.OTCPK: AGTX | $801.34K | $— | — |
| Hindustan Bio Sciences LimitedBSE: 532041 | $782.54K | Rs7.35 | +1.80% |
| Mosaic ImmunoEngineering, Inc.OTCPK: CPMV | $765.49K | $0.11 | +73.28% |
| Scinai Immunotherapeutics Ltd.NasdaqCM: SCNI | $758.13K | $1.21 | -9.02% |
| Helix BioMedix, Inc.OTCPK: HXBM | $739.29K | $3.29 | -34.20% |
Figures last refreshed Oct 4, 2026.